Educair

Welcome to

educair

. *

I confirm I that I am a healthcare professional registered in Saudi Arabia

. *

If you haven’t consented to receive GSK email or mobile communication, tick the box to opt in. Note: emails or SMSs may contain promotional information from GSK & its group. You can change your mind at any time and unsubscribe.

. *

By ticking this box, you give your consent to GSK to process your personal data for meeting the requirements of The Guide and disclose the below listed information to meet the SFDA transparency requirements. If you do not grant your consent or later withdraw your consent, GSK will regret to include you at any of its activities or services to ensure full alignment with local authorities’ regulations. Disclosure will start for any transfer of value/service from GSK as of October 1st, 2018 as per SFDA requirements. In case of Consent withdrawal, GSK will still be committed to SFDA requirements of disclosure during the period of consent. If you wish to access or correct any of your information held or disclosed by GSK or withdraw your consent, you may get in contact with the “Authorized Representative” of GSK through the e-mail address below: [email protected]. We are committed to respect the SFDA Disclosure and Transparency Initiative Guide #65925U (The Guide), which requires transparency with regards to financial relationships between Pharmaceutical /medical firms and health care professionals (HCPs) as well as health care institutions (HCIs) operating in Kingdom of Saudi Arabia. To meet these requirements, GSK must disclose any transfer of value / service provided by GSK to HCPs/HCIs to the SFDA while also adhering to the applicable privacy regulations in the Kingdom of Saudi Arabia.

This page is intended for Saudi Arabia healthcare professionals attending GSK standalone medical educational activity only.

For more information, please refer to the prescribing information or contact GSK: P.O Box 55850, Jeddah, 21544, Kingdom of Saudi Arabia. Telephone: +966 12 653 6666 or via [email protected]

To report Adverse Event/s associated with the use of GSK product/s, please contact us via [email protected]

To report Quality related product complaint/s associated with the use of GSK product/s, please contact us via [email protected]

For GSK privacy statement, Click HERE.

For GSK terms of use, Click HERE.

Trademarks are owned by or licensed to the GSK group of companies. Copyright © GlaxoSmithKline 2023. All rights reserved.

NX-SA-FFV-WBAN-230001 | preparation date Apr 2023